Health ❯ Regulatory Affairs ❯ FDA Approval ❯ Clinical Trials

Drug Safety

Novo Nordisk Raises Metsera Bid to $10 Billion, Outpacing Pfizer’s $8.1 Billion Counter

Delaware courts are fast-tracking Pfizer’s legal challenges ahead of a Nov. 13 shareholder vote.

FDA Approves Palsonify, First Once-Daily Oral Treatment for Acromegaly